Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Effects of 『Geum-Gwe-Yo-Ryak(金匱要略)』 Prescription for Chest Pain Including Kwaruhaebaekbanha-tang and Kwaruhaebaekpaekju-tang on Macrophage Polarization

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2019, v.40 no.2, pp.51-62
https://doi.org/10.13048/jkm.19016








  • Downloaded
  • Viewed

Abstract

Objectives: This study was designed to evaluate the macrophages polarization of traditional Korean medicine on cardiac pain about Geum-Gwe-Yo-Ryak's two prescriptions including Kwaruhaebaekbanha-tang (KHB) and Kwaruhaebaekpaekju-tang (KHP). Materials and methods: Flow cytometry analysis was used to measure the changes in the ratio of M1 type and M2 type macrophages. Protein expression of nuclear factor-like 2 (Nrf2), heme oxygenase-1 (HO-1), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) were measured by Western Blot, and ABCA1 and SR-B1 were detected by real time PCR (RT-PCR). Intracellular lipid accumulation was measured by Oil Red O staining (ORO staining). Results: KHB and KHP increase anti-oxidative activity related protein levels including Nrf2 and HO-1. Furthermore, KHB and KHP inhibit lipid accumulation on intracellular levels through induction of ATP binding receptor cassette subfamily A member 1 (ABCA1) and scavenging receptor class B member 1 (SR-B1), respectively. Finally, KHB and KHP also blocked pro-inflammatory mediators including tumor necrosis factor-alpha (TNFα) and interleukin-6 (IL-6), iNOS and COX-2 expression. Conclusion: This study suggests that KHB and KHP potently regulate the M1/M2 macrophage polarization.

keywords
Geum-Gwe-Yo-Ryak, Kwaruhaebaekbanha-tang, Kwaruhaebaekpaekju-tang, Macrophage polarization


Reference

1

1. Tong X, Yang Q, Ritchey MD, George MG, Jackson SL, Gillespie C, et al. The burden of cerebrovascular disease in the United States. Prev Chronic Dis. 2019;16(52):180411.

2

2. Terentes-Printzios D, Vlachopoulos C, Xplanteris P, Ioakeimidis N, Aznaouridis K, et al. Cardiovascular risk factors accelerate progression of vascular aging in the general population:Results from CRAVE study (Cardiovascular Risk Factors Affecting Vascular Age). Hypertension. 2017;70(5):1057-64.

3

3. John Hall. Guyton and Hall Textbook of Medical Physiology. 12th ed. Korea: Bupmoon Education. 2017.

4

4. Poupel L, Combadiere C. Atherosclerosis: on the trail of chemokines. Biol Aujourdhui. 2010;204(4):285-93.

5

5. Munteanu AI, Raica M, Zota EG. Immunohistochemical study of the role of mast cells and macrophages in the process of angiogenesis in the atherosclerotic plaques in patients with metabolic syndrome. Arkh Patol. 2016;78(2):19-28.

6

6. Chati A, Eckel RH. Lipids, lipoproteins, and cardiovascular disease: Clinical pharmacology now and in the future. J Clin Endocrinol Metab. 2016;101(3):804-14.

7

7. Pigarevsky PV, Snegova VA, Nazarov PG. Macrophages and their role in destabilization of an atherosclerotic plaque. Kardiologiia. 2019;59(4):88-91.

8

8. Saqib U, Sarkar S, Suk K, Mohammad O, Baig MS, Savai R. Phytochemicals as modulators of M1-M2 macrophages in inflammation. Oncotarget. 2018;9(25):17937-50.

9

9. Liu Y, Wang X, Pang J, Zhang H, Luo J, Qian X, et al. Protocatechuic acid attenuates atherosclerosis by inhibiting M1 and promoting M2 macrophage polarization. J Agric Food Chem. 2019;67(3):807-18.

10

10. 전국한의과대학 심계내과학교실. 東醫心系內科學. 서울: 서원당. 2001.

11

11. 이학로. 금궤요략의 순환구조. 대전:주민출판사. 2000.

12

12. Ren Y, Chen ZQ, Zhang MZ, Guo LH, He DY. Cluster analysis of medication laws for treating coronary heart disease by distinguished veteran doctors of traditional Chinese medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36(4):411-4.

13

13. Bertrand MJ, Tardif JC. Inflammation and beyond: New directions and emerging drugs for treating atherosclerosis. Exper Opin Emerg Drug. 2017;22(1):1-26.

14

14. Paseban M, Butler AE, Sahebkar A. Mechanisms of statin-induced new-onset diabetes. J Cell Physiol. 2019;234(8):12441-61.

15

15. Richard A. Harvey. Lippincott’s Illustrated Reviews: Pharmacology. 6th ed. Seoul: Shinil Books. 2015.

16

16. Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine form natural products. Molecules. 2016;29(5):559.

17

17. Yu X, Tang L, Wu H, Zhang X, Luo H, Guo R. et al. Trichosanthis Fructus: botany, traditional uses, phytochemistry and pharmacology. J Ethonopharmacol. 2018;224:177-94.

18

18. Yao ZH, Qin ZF, Dai Y, Yao XS. Phytochemistry and pharmacology of Allii Macrostemonis Bulbus, a traditional Chinese medicine. Chin J Nat Med. 2016;14(7):481-98.

19

19. 전국한의과대학 공동교재편찬위원회. 本草學. 서울:영림사. 2007.

20

20. Mao S, Chenf L, Wu L. Study on anticonvulsive effect of Rhizoma pinelliae. Zhong Yao Cai. 2001;24(11):813-4.

21

21. Mimura J, Itoh K. Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic Biol Med. 2015;88:221-32.

22

22. Ahotupa M. Oxidized lipoprotein lipids and atherosclerosis. Free Radic Res. 2017;51(4):439-47.

23

23. Favari E, Chroni A, Tietge UJ, Zantti I, Escola-Gil JC, Bernini F. Cholesterol efflux and reverse cholesterol transport. Handb Exp Pharmacol. 2015;224:181-206.

24

24. Libby P, Ridker PM, Hansson GK. Inflammation in Atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129-38.

상단으로 이동

Journal of Korean Medicine